Iofina plc (IOF) - Total Liabilities

Latest as of December 2025: GBX23.53 Million GBX ≈ $2.86K USD

Based on the latest financial reports, Iofina plc (IOF) has total liabilities worth GBX23.53 Million GBX (≈ $2.86K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Iofina plc (IOF) net asset momentum to track the company's year-over-year net asset growth rate.

Iofina plc - Total Liabilities Trend (2006–2025)

This chart illustrates how Iofina plc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Iofina plc generate to measure how efficiently the company converts operating cash flow to free cash.

Iofina plc Competitors by Total Liabilities

The table below lists competitors of Iofina plc ranked by their total liabilities.

Company Country Total Liabilities
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI
USA $5.83 Million
Ellen AB (publ)
ST:ELN
Sweden Skr4.67 Million
Asia Pacific Investama Tbk PT
JK:MYTX
Indonesia Rp3.96 Trillion
JZ Capital Partners Ltd
LSE:JZCP
UK GBX673.00K
INFINITII AI INC.
F:Y31
Germany €2.30 Million
Aptitude Software Group PLC
LSE:APTD
UK GBX47.95 Million
Urban-Gro Inc
NASDAQ:UGRO
USA $42.08 Million
AVRO INDIA LIMITED
NSE:AVROIND
India Rs369.88 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Iofina plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IOF market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.64 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.42 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Iofina plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Iofina plc (2006–2025)

The table below shows the annual total liabilities of Iofina plc from 2006 to 2025.

Year Total Liabilities Change
2025-12-31 GBX23.53 Million
≈ $2.86K
+47.13%
2024-12-31 GBX15.99 Million
≈ $1.95K
+1.39%
2023-12-31 GBX15.77 Million
≈ $1.92K
+7.04%
2022-12-31 GBX14.73 Million
≈ $1.79K
+1.73%
2021-12-31 GBX14.48 Million
≈ $1.76K
-24.48%
2020-12-31 GBX19.18 Million
≈ $2.33K
-21.57%
2019-12-31 GBX24.45 Million
≈ $2.98K
-18.97%
2018-12-31 GBX30.18 Million
≈ $3.67K
+1.25%
2017-12-31 GBX29.80 Million
≈ $3.63K
+24.82%
2016-12-31 GBX23.88 Million
≈ $2.91K
-0.82%
2015-12-31 GBX24.07 Million
≈ $2.93K
+4.23%
2014-12-31 GBX23.10 Million
≈ $2.81K
+18.76%
2013-12-31 GBX19.45 Million
≈ $2.37K
+517.19%
2012-12-31 GBX3.15 Million
≈ $383.40
+34.94%
2011-12-31 GBX2.34 Million
≈ $284.12
-15.38%
2010-12-31 GBX2.76 Million
≈ $335.76
-18.93%
2009-12-31 GBX3.40 Million
≈ $414.14
+260.92%
2008-12-31 GBX943.08K
≈ $114.75
+105.86%
2007-12-31 GBX458.11K
≈ $55.74
-41.69%
2006-12-31 GBX785.64K
≈ $95.59
--

About Iofina plc

LSE:IOF UK Specialty Chemicals
Market Cap
$1.28 Million
GBX10.55 Billion GBX
Market Cap Rank
#30397 Global
#766 in UK
Share Price
GBX55.00
Change (1 day)
+0.00%
52-Week Range
GBX20.50 - GBX59.00
All Time High
GBX59.00
About

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermed… Read more